News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–50
Matches
50
Sources here
8
Companies here
1
Search results Stored financial headlines

Active search

50 matching headlines

Ticker or company: QTRXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Quanterix Corp (QTRX) Cash Flow

This article provides a detailed historical cash flow statement for Quanterix Corp (QTRX), including operating, investing, and financing cash flows, presented in a quarterly and annual format. It also offers definitions and explanations for key cash flow metrics such as operating cash flow, investing …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Quanterix Corporation Revenue Breakdown – NASDAQ:QTRX

Quanterix Corporation (NASDAQ: QTRX) generated $138.90 million USD in revenue last year, primarily from its Ultra-sensitive Digital Immunoassay Platforms segment. North America was the largest contributor to revenue, accounting for $85.36 million USD. This information provides a snapshot of the company's financial performance by …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Quanterix Corp (QTRX) Income Statement

This article provides a detailed quarterly and annual income statement for Quanterix Corp (QTRX), offering financial data from FY2016Q1 through FY2026Q1. It includes metrics like total revenue, cost of revenue, operating expenses, and net income, alongside year-over-year percentage changes. The report also features an …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

QTRX|Quanterix Corp|Price:2.850|Chg%:-0.010

Quanterix Corp (QTRX) shows relatively healthy fundamentals and significant growth potential, although its stock price has been trending sideways. The company's valuation is considered fairly valued within the Healthcare Equipment & Supplies industry, and institutional ownership is notably high. Analysts currently rate the stock …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

QTRX|Quanterix Corp|Price:3.670|Chg%:-0.250

Quanterix Corp (QTRX) shows relatively healthy fundamentals and significant growth potential, although its stock price has been trending sideways. The company's valuation is considered fairly valued within the Healthcare Equipment & Supplies industry, and institutional ownership is notably high. Analysts currently rate the stock …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Seeking Alpha Deals and strategy Main company 🇺🇸 United States

Quanterix: Trading Below 1x Sales Despite A Changing Story (NASDAQ:QTRX)

Quanterix (QTRX) is undergoing a significant transformation under new management following the Akoya acquisition, aiming for cash flow breakeven in the second half of 2026. The company plans to achieve this through cost synergies, improved commercial execution, and leveraging its established base for recurring …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Ad Hoc News Earnings Main company 🇺🇸 United States

Quanterix stock trades lower despite stronger revenue and margin progress

Quanterix (QTRX) stock is trading lower despite reporting stronger revenue growth and improved gross margins in its latest fiscal year. The company saw double-digit revenue growth in 2023, narrowing its net loss while maintaining a solid cash position. Investors are weighing these operational improvements …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Nigeria Market update Main company 🇺🇸 United States

Form 4 Quanterix Corp For: 16 July By Investing.com

This article from Investing.com is a standard SEC Form 4 filing for Quanterix Corp (QTRX), indicating insider transaction details for July 16. It briefly mentions the company's stock performance and provides a link to view comments. The content primarily serves as a placeholder for …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Quanterix CFO’s 141,820-Share Award Vests Over Four Years

Quanterix Corporation announced an inducement grant of 141,820 restricted stock units (RSUs) to Jason Faessler upon his commencement as Chief Financial Officer and Treasurer. These RSUs, representing shares of Quanterix common stock, will vest in four equal annual installments over four years, contingent on …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Market source Deals and strategy Main company 🇺🇸 United States

Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation announced an inducement grant to Jason Faessler upon his employment as Chief Financial Officer and Treasurer. The grant consists of 141,820 restricted stock units (RSUs) vesting over four years, aligning with Nasdaq Listing Rule 5635(c)(4) and approved by the company's Compensation Committee. …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Quanterix Corp (QTRX) CTO converts 1,558 RSUs, withholds shares for taxes

Quanterix Corp's Chief Technology Officer, Michael Francis Miller, converted 1,558 restricted stock units (RSUs) into common stock on July 15, 2026. In connection with this transaction, 467 shares were withheld to cover tax obligations. After these non-open-market transactions, Miller directly owns 35,058 common shares …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Quanterix Corp (NASDAQ: QTRX) grants 141,820 RSUs to its CFO

Quanterix Corp granted 141,820 restricted stock units (RSUs) to its Chief Financial Officer, Jason F. Faessler, on July 15, 2026. These RSUs will vest in four equal annual installments over the next four years, contingent on his continued employment with the company. Following this …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Seeking Alpha Market update Main company 🇺🇸 United States

Quanterix wins coverage for Alzheimer’s test (QTRX:NASDAQ)

Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer’s test, LucentAD Complete, will be covered by Elevance Health’s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the diagnostic …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Anthem Blue Cross covers Quanterix Alzheimer’s blood test

Anthem Blue Cross and Blue Shield will now cover Quanterix Corporation's LucentAD Complete blood-based biomarker test for Alzheimer's disease for its 40 million members, effective July 1, 2026. This announcement led to a 5% increase in Quanterix's stock. The company also highlighted a new …

QTRX main company
Sharemaestro market context Price below Trend Line 52 weeks -46.4% QTRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context